Print Page     Close Window     

Investor Overview

Corporate Profile

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is seeking to unlock the full potential of biologic therapies by avoiding unwanted immune responses. Selecta’s tolerogenic Synthetic Vaccine Particles (SVP™) technology platform is designed to enable a range of novel biologics for rare and serious diseases that require new treatment options. The company’s current proprietary pipeline includes SVP-enabled enzyme, oncolo... View more »

Recent News
View all press releases »
Download DocumentationSept 12, 2017
Selecta September 2017 Investor Presentation
Upcoming Events
Sep 26, 2017 9:10 a.m. ET
Selecta Biosciences Inc at the 2017 Cantor Fitzgerald Global Healthcare Conference
remind me days before the event
Enter your e-mail address 
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
0.00 (0.00%)
Stock chart for: SELB.O.  Currently trading at $19.74 with a 52 week high of $28.00 and a 52 week low of $10.27.
Data as of Sep 21, 2017 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078

Data provided by Nasdaq. Minimum 15 minutes delayed.

© Selecta Biosciences, Inc. All rights reserved.